Aaron Schuchart

Prior to joining Aeglea, Mr. Schuchart served as senior vice president of business development and strategic alliances at Coherus Biosciences, where he played a role in growing the company from early platform stage to a fully integrated, late-stage clinical company. Prior to Coherus, Mr. Schuchart was head of business development and strategic planning at Novartis’ diagnostics division until its acquisition by Grifols. He also advised on and led portfolio planning projects, financings, and strategic transactions for numerous biotech clients as managing director of Proaltus Partners, LLC. Earlier in his career, he served in various business and operational leadership roles at Mendel Biotechnology and Amgen. Mr. Schuchart holds a B.S. in accounting from Texas Tech University, an M.B.A. from the UCLA Anderson School of Management, and is a Certified Licensing Professional (CLP).

Aaron Schuchart is the Chief Business Officer at Aeglea BioTherapeutics, based in United States, North America. With a background in Biotechnology, Aaron Schuchart has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.